High Level of Pretreatment and Acquired Human Immunodeficiency Virus Drug Resistance in El Salvador: A Nationally Representative Survey, 2018-2019.

MLA

Girón-Callejas, Amalia, et al. “High Level of Pretreatment and Acquired Human Immunodeficiency Virus Drug Resistance in El Salvador: A Nationally Representative Survey, 2018-2019.” Open Forum Infectious Diseases, vol. 9, no. 11, Nov. 2022, p. ofac580. EBSCOhost, https://doi.org/10.1093/ofid/ofac580.

APA

Girón-Callejas, A., García-Morales, C., Mendizabal-Burastero, R., Quezada, A., Ruiz, L., Arguera, N., Sorto, S., Nieto, A. I., Tapia-Trejo, D., López-Sánchez, D. M., Pérez-García, M., Cruz, L., Andino, R., Sajquim, E., Juárez, S. I., Farach, N., Ravasi, G., Northbrook, S., Reyes-Terán, G., & Ávila-Ríos, S. (2022). High Level of Pretreatment and Acquired Human Immunodeficiency Virus Drug Resistance in El Salvador: A Nationally Representative Survey, 2018-2019. Open Forum Infectious Diseases, 9(11), ofac580. https://doi.org/10.1093/ofid/ofac580

Chicago

Girón-Callejas, Amalia, Claudia García-Morales, Ricardo Mendizabal-Burastero, Alma Quezada, Lisette Ruiz, Nelly Arguera, Salvador Sorto, et al. 2022. “High Level of Pretreatment and Acquired Human Immunodeficiency Virus Drug Resistance in El Salvador: A Nationally Representative Survey, 2018-2019.” Open Forum Infectious Diseases 9 (11): ofac580. doi:10.1093/ofid/ofac580.